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Toxoplasma gondii, the etiological agent of toxoplasmosis,
utilizes stage-specific expression of antigenically distinct gly-
cosylphosphatidylinositol-tethered surface coat proteins to
promote and establish chronic infection. Of the three infec-
tive stages ofT. gondii, sporozoites are encapsulated in highly
infectious oocysts that have been linked to large scale out-
breaks of toxoplasmosis. SporoSAG (surface antigen glyco-
protein) is the dominant surface coat protein expressed on
the surface of sporozoites. Using a bioinformatic approach,
we show that SporoSAG clusters with the SAG2 subfamily of
the SAG1-related superfamily (SRS) and is non-polymorphic
among the 11 haplogroups of T. gondii strains. In contrast to
the immunodominant SAG1 protein expressed on tachyzoites,
SporoSAG is non-immunogenic during natural infection. We
report the 1.60 A˚ resolution crystal structure of SporoSAG
solved using cadmium single anomalous dispersion. SporoSAG
crystallized as a monomer and displays unique features of the
SRS -sandwich fold relative to SAG1 and BSR4. Intrigu-
ingly, the structural diversity is localized to the upper sheets
of the -sandwich fold and may have important implications
for multimerization and host cell ligand recognition. The
structure of SporoSAG also reveals an unexpectedly acidic
surface that contrasts with the previously determined SAG1
and BSR4 structures where a basic surface is predicted to play
a role in binding negatively charged glycosaminoglycans. Our
structural and functional characterization of SporoSAG pro-
vides a rationale for the evolutionary divergence of this key
SRS family member.
Toxoplasma gondii is a highly prevalent, obligate, intracellu-
lar protozoan parasite that infects nearly one-third of the
human population (1, 2). Since its recognition as the causative
agent of toxoplasmosis in the late 1930s, many clinical manifes-
tations have been attributed to T. gondii infections including
lymphadenopathy, ileitis, encephalitis, and/or blinding ocular
infections in both children and adults (1, 3–8). T. gondii infec-
tions can also be lethal to a developing fetus and immunocom-
promised, cancer, AIDS, and organ transplant patients. A key
feature of the ability of T. gondii to infect and multiply in virtu-
ally any warm blooded animal is a complex life cycle that
encompasses both sexual (sporozoite) and asexual (tachyzoite
and bradyzoite) stages of development. Sexual replication oc-
curs exclusively in felines, whereas asexual division occurs in
all warm blooded hosts. Three main routes of infection exist
for T. gondii. Congenital infection occurs with maternal
transmission of tachyzoites via the placenta to a fetus,
whereas ingestion of bradyzoites occurs when tissue cysts in
undercooked meat are consumed, and finally, infection with
sporozoites occurs when food or water contaminated with
oocysts is consumed. A remarkable trait of T. gondii is its
ability to differentiate from the ingested bradyzoite or sporo-
zoite into the fast replicating tachyzoite, facilitating rapid
dissemination throughout the host. Upon challenge by the
immune system, the tachyzoite converts to the slow growing,
encysted bradyzoite responsible for establishing a chronic,
transmissible infection.
Historically, meat containing T. gondii tissue cysts was con-
sidered the major route of transmission to humans; however,
improved farming practices have considerably reduced the like-
lihood of infected livestock (9). The prevalence of T. gondii in
felines, however, remains high (10–14). Shedding of T. gondii
oocysts containing infectious sporozoites by both feral and
domestic cats continues to result in widespread environmental
contamination, due both to large numbers of parasites shed (as
many as 1 million/cat) and to the resistance of oocysts to envi-
ronmental degradation (15). Localized incidences of water-
borne transmission as well as substantial outbreaks due to
contaminated water supplies or soil have been extensively
documented (16–21). Due to the potentially broad scale of an
outbreak, environmental transmission of T. gondii through
sporozoite ingestion arguably poses the most significant global
risk.
Stage conversion in T. gondii coincides with a major change
in expression of surface antigens belonging to the surface anti-
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gen 1 (SAG1)4-related sequences (SRS) family, which are pre-
dicted to play a dual role in parasite attachment and regulation
of host immunity to establish chronic infection (22–26). Struc-
tural requisites of this superfamily are an N-terminal secretion
signal, a glycosylphosphatidylinositol (GPI) anchor, and a com-
plement of conserved amino acids that typically include six cys-
teines per SRS monomer that participate in three disulfide
bonds. Sequencing of the T. gondii genome has revealed more
than 160 SRS family members (27). Recent structural studies of
the predominantly tachyzoite-expressed SAG1 and bradyzoite-
expressed BSR4 identified a topologically defined groove that is
postulated to coordinate host cell surface molecules such as
heparin (25, 28).
Although SAG1 and BSR4 show differential expression pat-
terns, they are both members of the SAG1 family, which are
phylogenetically divergent from the SAG2 family of SRS anti-
gens (27). Interestingly, paralogs within the SAG2 family share
less identity (20%) when compared with the SAG1 family
(30%). Members of the SAG2 family also differ in terms of
open reading frame size, with the smaller SAG2A and SAG2B
proteins consisting of a single SAG domain, whereas SAG2C
and SporoSAG contain two SAG domains interrupted by a sin-
gle intron. Despite the increased divergence of the SAG2 family
relative to the SAG1 family, it is the SAG2 family that is more
conserved across other tissue-dwelling coccidia (27).
To date, only two structural descriptions have been reported
for the 160 SRS superfamily: one for the tachyzoite-expressed
SAG1 (25) and the second for the bradyzoite-expressed BSR4
(28). To determine the structural and functional implications of
a sporozoite-expressed SRS protein, we report the 1.60 Å reso-
lution crystal structure and immunoreactivity profile of the
major GPI-tethered cell surface antigen expressed in sporozo-
ites. The characterization of SporoSAG also provides the first
structural view of a T. gondii SRS family member from the
infectious sporozoite stage and from the SAG2 subfamily.
EXPERIMENTAL PROCEDURES
Bioinformatics—The protein sequence alignment for phylo-
genetic reconstruction was constructed using the program
PROMALS3D (29). The structures of SAG1 (1KZQ), BSR4
(2JKS), and SporoSAG (2WNK) were used to anchor the align-
ment. Besides the choice of initial sequence alignment method
(PROMALS), default parameters were implemented. The
resulting alignment was hand-edited in Geneious (30). Due to
the prevalence of indels in the sequence alignment, positions
where the 50% consensus was a gapwere ignored for tree build-
ing. A neighbor-joining tree was generated from a protein dis-
tance matrix, using PROTDIST and NEIGHBOR from the
PHYLIP package (version 3.68) (31). The rate variation between
sites was gamma distributed with an alpha value of 0.5. A total
of 10,000 bootstraps were run, and only nodes receiving50%
support were resolved in the tree displayed.
SporoSAG Immunogenicity—Sera from infected patients,
mice, and rabbits were tested for reactivity against insect cell-
produced SporoSAG by enzyme-linked immunosorbent assay,
as described previously by Kong et al. (32). Briefly, infected
patient, mouse, and rabbit sera (1:80 dilution) were incubated
overnight with 0.3 g of baculovirus-expressed recombinant
proteins. Positive reactions were detected using horseradish
peroxidase-conjugated anti-human, anti-mouse, or anti-rabbit
polyvalent IgG, IgA, and IgM detection antibodies (Sigma),
developed with 2,2-azino-bis(3-ethylbenzthiazoline-6-sul-
phonic acid) peroxidase substrate (Kirkegaard & Perry Labora-
tories, Inc.), and the absorbance was measured at 405 nm after
60 min. Serum samples from a known uninfected volunteer
served as a negative control, and serum from a patient infected
with Type II strain oocysts was included as the positive control,
respectively. For murine and rabbit infections, positive control
sera were derived by injecting bradyzoite cysts or sporulated
oocysts of the Type II Me49 strain via the oral (bradyzoites,
oocysts) and subcutaneous routes (oocysts). To obtain sporu-
lated oocysts, fecal floats from cats shedding T. gondii oocysts
were incubated in 2% sulfuric acid for 1 week at room temper-
ature to allow for sporulation. Sporulated oocysts were
counted, and either 100 or 1000 oocysts were fed orally or
injected subcutaneously into mice or rabbits. Sera reactivity
against insect cell-produced SAG1 or SRS2 was measured as
the positive control for infectionwithToxoplasma, and reactiv-
ity against a generic insect cell-produced protein was included
as a negative control.
Molecular Cloning and Recombinant Virus Production—The
tandem SAG domains of SporoSAG are separated by an inter-
vening intronic sequence therefore requiring a multistep PCR
approach to generate a single cDNA template. Each domain
was initially amplified separately from T. gondii RH genomic
DNA (Ex1, forward, 5-cagactccatgggaCCTGAAGCAACTT-
CCTGTG-3; Ex1 (overlap), reverse, 5-CACCGGAGCCT-
GTGGTGCCGCTTTGACGAG-3; Ex2 (overlap), forward,
5-AAGCGGCACCAAGGCTCCGGTGTGTTCGG-3; Ex2,
reverse, 5-ctgtctggcggccgcAACGGTTACCAAAACTTTGC-
AGG-3). Domain 1 and domain 2 amplicons were then com-
bined, allowing homologous regions (underlined) to anneal and
extend, resulting in a single cDNA template. This product was
then amplified (Ex1 forward and Ex2 reverse) and cloned into
NcoI/NotI-digested pAcGP67b (Pharmingen) in-frame with a
C-terminal hexahistidine tag. Expression of the sequence-veri-
fied clone was conducted in the baculovirus insect cell system.
Primary virus was generated by co-transfection of Spodoptera
frugiperda (Sf9) insect cells with linearized SapphireTM baculo-
virus DNA (Orbigen) and the SporoSAG/pAcGP67b modified
clone. The recombinant SporoSAGencoding primary viruswas
subsequently amplified to generate high titer virus for use in
protein production.
Recombinant Protein Expression and Purification—A 4-liter
volume of High Five insect cells was infected with 2.5 ml of
amplified SporoSAG virus/liter of culture. The culture was har-
vested after 65 h and centrifuged at 450 g to remove cellular
debris, and the supernatant was concentrated using tangential
flow and buffer-exchanged into buffer A (20 mM HEPES, pH 8,
1 MNaCl, 30mM imidazole). SporoSAGwas selectively purified
HisTrapFF nickel affinity with fractions analyzed by SDS-
PAGE and pooled based on purity. Removal of the SporoSAG
4 The abbreviations used are: SAG, surface antigen glycoprotein; SRS, SAG-
related sequence; GPI, glycosylphosphatidylinositol; SporoSAG, major
sporozoite surface antigen glycoprotein.
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hexahistidine tag with thrombin was followed by gel filtration
(Superdex 75) in buffer B (20 mM HEPES, pH 8, 150 mM NaCl)
and anion exchange chromatography (Source 30Q) in buffers C
(20mMHEPES, pH 8, 10mMNaCl) andD (20mMHEPES, pH 8,
500 mM NaCl) to produce sufficiently pure protein for crystal-
lization studies. The purified SporoSAGprotein beginswith the
N terminus sequence GSAMGPEAT (GS remaining after
thrombin cleavage and AMG derived from the NcoI site) and
extends throughLVTVAAALVPR (AAA from theNotI site and
LVPR remaining after thrombin cleavage), resulting in a total
molecular mass of 25,657 Da.
Crystallization, Data Collection, and Processing—Crystalli-
zation trials were set up with Crystal screen HTTM, Crystal
screen 2 HTTM, and PEG/ION screenTM (Hampton Research)
and Precipitant SynergyTM Primary 64 crystallization screen
(Emerald Biosystems) in 96-well plates (Emerald Biosystems).
The final drops consisted of 1 l of SporoSAG (at 25 mg/ml) in
20 mM HEPES, pH 8, 100 mM NaCl, and 1 l of reservoir solu-
tion equilibrated against 100l of reservoir solution. Crystals of
native SporoSAG were observed within 3 days in 25% polyeth-
ylene glycol 3350, 0.1 M Tris, pH 8.5, whereas cadmium-deri-
vatized crystals of SporoSAG grew in 1 week in 20% polyethyl-
ene glycol 4000 with 0.2 M Cd(NO3)2. SporoSAG crystals were
cryoprotected in mother liquor plus 20% glycerol for 30 s and
flash cooled at 100Kdirectly in the cryostream.Diffraction data
were collected on a Rigaku R-axis IV area detector coupled
to anMM-002 x-ray generator with Osmic “blue” optics and an
Oxford Cryostream 700. Diffraction data for the native Sporo-
SAG crystals to 1.60 Å and cadmium-derivatized crystals to
2.15 Å were processed using Crystal Clear software with
d*TREK (33). Data collection and refinement statistics are pre-
sented in Table 1.
Structure Solution and Refinement—A total of five cadmium
sites were identified and refined using autoSHARP (34). High
quality phases of the cadmiumderivative were obtained follow-
ing density modification that enabled building and registering
of 80% of the backbone using ARP/Warp (35). The partially
built SporoSAG structure was then used as a search model in
molecular replacement using MOLREP (36) with the high res-
olution native data set. The remaining structure was built man-
ually, and solvent atoms were selected using COOT (37) and
refined with REFMAC (38) to an Rcryst of 19.0 and an Rfree of
24.0%. All solvent atoms were inspected manually before de-
position. Stereochemical analysis of the refined SporoSAG
structure was performed with PROCHECK and SFCHECK in
CCP4 (39) with the Ramachandran plot showing excellent ste-
reochemistrywith 99.3%of the residues in themost favored and
additional allowed conformations and no residues modeled in
disallowed orientations. Overall, 5% of the reflections were set
aside for calculation of Rfree. Data collection and refinement
statistics are presented in Table 1.
RESULTS ANDDISCUSSION
SporoSAG Is a SAG2 Subfamily SRS Protein—Phylogenetic
clustering analyses of the 161 bioinformatically related SRS
proteins have previously identified a bifurcated tree that estab-
lished two evolutionarily distinct sequence clades, or subfami-
lies, related to SAG1 and SAG2, respectively (27). To determine
the SRS subgroup the sporozoite protein SporoSAGmost closely
alignedwith, prototypic sequences of SRS proteins known to clus-
ter with the SAG1 subfamily (SAG1, SAG3, SAG5A, SAG5C,
BSR4, SRS2, and SRS9) and with the SAG2 subfamily (SAG2A,
SAG2C, SAG2Y, SRS20A, SRS23, SRS37A, SRS47D, and
SRS47F) were aligned with SporoSAG using the structure-based
PROMALS3D alignment program. The structures of SAG1,
BSR4, and SporoSAG were used to anchor the alignment (see
supplemental Fig. 1). A neighbor-joining tree was constructed
using the PROTDIST and NEIGHBOR programs in the PHYLIP
3.68 suite of phylogenetic software, and 10,000 bootstrap repli-
cates were run. Only nodes receiving greater than 50% support
were resolved in the tree (Fig. 1). The bootstrap with neighbor-
joining analysis robustly supported the inclusion of the dominant
sporozoite surface antigen SporoSAG as a distal member of the
SAG2 clade of sequences. A domain-based tree was also gener-
ated, and both domains of SporoSAG clustered with the SAG2
subfamily (data not shown).
SporoSAG Is Not Immunogenic during Natural Infection—
SAG1 and SAG2 are the dominant tachyzoite antigens ex-
pressed against which the majority of the humoral immune
response is focused (40–44). To determine whether the domi-
nant sporozoite surface antigen SporoSAG is likewise immu-
nodominant during T. gondii infections, we evaluated sera
reactivity from known T. gondii-infected hosts, across a range
of species and across routes of infection (Fig. 2). Ten and three
serum samples (designated Oocyst), collected from patients
whose infection was linked epidemiologically to the consump-
tion of water-borne oocysts from outbreaks in Victoria, Canada
TABLE 1
Data collection and refinement statistics
Values in parentheses are for the highest resolution shell. NA, not applicable.
Native SporoSAG Cd(NO3)2 SporoSAG
Data collection
Spacegroup P6 P21212
a, b, c (Å) 106.42, 106.42, 31.60 102.62, 72.97, 30.66
, ,  (degrees) 90, 90, 120 90, 90, 90
Wavelength 1.5418 1.5418
Resolution (Å) 30.72-1.60 28.26-2.15
Measured reflections 223926 158772
Unique reflections 52494 13203
Redundancy 4.3 (3.5) 12.0 (9.9)
Completeness (%) 99.3 (95.5) 100 (98.8)
I/(I) 18.1 (2.1) 21.5 (5.3)
Rmergea 0.033 (0.451) 0.107 (0.441)
Figure of merit 0.29724
Refinement statistics
Resolution range (Å) 23.42–1.60 (1.69–1.60) 28.30–2.15 (2.20–2.15)
Rcrystb/Rfreec 0.190/0.240 0.236/0.289
No. of atoms
Protein 1623 1600
Solvent 310 168
Cadmium NA 5
B-values
Protein (Å2) 18.90 21.56
Solvent (Å2) 31.75 30.19
Cadmium (Å2) NA 37.57
r.m.s.d deviation from
ideality
Bond lengths (Å) 0.010 0.019
Bond angles (degrees) 1.303 1.949
a RmergehkliIhkl,i (Ihkl)/hkli Ihkl,i, where (Ihkl) is the average of symmetry-
related observations of a unique reflection.
b RcrystFobs Fcalc/Ffobs, where Fobs and Fcalc are the observed and the calcu-
lated structure factors, respectively.
c Rfree is R using 5% of reflections randomly chosen and omitted from refinement.
d r.m.s., root mean square.
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(1995) and Santa Isabel do Ivai, Brazil (2001), respectively, were
tested for the presence of antibodies that specifically reacted
against SporoSAG (18, 19). Control samples comprised serum
from pregnant patients whose T. gondii infection was detected
during routine screening andwhowere presumably infected via
the consumption of undercookedmeat (designatedBradyzoite)
(12, 45). Patient sera were evaluated across a range of titers to
SAG1, with higher titers prioritized to maximize the possibility
of detecting a reaction against SporoSAG. Sera from an unin-
fected individual and from aType II strain oocyst-infected indi-
vidual were included as the negative and positive controls,
respectively. No antibody reactivity (neither IgM, IgA, nor IgG)
was detected against SporoSAG in any of the human samples,
suggesting that the host immune system does not mount an
antibody response to this protein (Fig. 2A). This was not the
result of a failure of these individuals to mount antibody
responses against Toxoplasma because all patients possessed
anti-SAG1 reactivity. Identical results were obtained using sera
acquired from either bradyzoite-infected or sporulated oocyst-
infected mice inoculated by peroral injection or via subcutane-
ous inoculation and developed using polyvalent anti-mouse
secondary antibodies to detect IgA, IgM, and IgG (Fig. 2B). The
same sporulated oocysts were also injected subcutaneously into
rabbits and yielded the same results (data not shown). The lack
of reactivity to SporoSAG during infection established that this
highly expressed, sporozoite-specific antigen is a poor candi-
date reagent for the development of a test capable of detecting
individuals infected by oocysts, a question of considerable epi-
FIGURE 1. SporoSAG is a SAG2 subfamily SRS protein. SporoSAG was
aligned with SAG1 and SAG2 subfamily sequences using the PROMALS3D
program and hand-edited in Geneious. A neighbor-joining tree was con-
structed using PROTDIST andNEIGHBOR (PHYLIP 3.68), and 10,000 bootstrap
replicates were run to identify supported nodes.
FIGURE2.T. gondii-infectedpatients fail tomountantibody responses to insect cell-producedSporoSAG.A, 19humanserumsamples frompatientswith
T. gondii infections epidemiologically linked to consumption of water-borne oocysts (Oocyst) or presumed bradyzoite transmission (Bradyzoite) were tested
against sera from an uninfected patient (Negative) and sera from a known Type II T. gondii oocyst infection (Positive).O.D., optical density. B, serum frommice
infected with 20 Type II Me49 bradyzoite cysts perorally or 100 Type II Me49 sporulated oocysts either perorally or subcutaneously were reacted against an
irrelevant baculovirus-expressed D2 antigen, recBSR4 protein (Control); SporoSAG; and the diagnostic proteins for T. gondii infection, SAG1 (human) or SRS2
(mouse). Enzyme-linked immunosorbent assay data for each serumwere normalized by dividing the optical density value obtained at 405 nm for each of the
Toxoplasma proteins by the optical density reading obtained for the irrelevant control D2 protein.
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demiologic importance.Wenext sought to solve the SporoSAG
structure to compare its evolutionary relationship and struc-
tural features with the solved structures for the tachyzoite
(SAG1) and bradyzoite (BSR4) proteins that belong to the
SAG1 subfamily of SRS proteins.
Overall Structure—The cloned SporoSAG construct begins
at Pro-3 and extends through Val-237, one residue short of the
predictedGPI anchor site, Ser-238, that tethers themature pro-
tein to the outermembrane ofT. gondii (Fig. 3A). Production of
SporoSAG in insect cells was followed by extensive purification
using nickel affinity, size exclusion, and ion exchange chroma-
tography and resulted in a protein that migrated as a single
band on an SDS-PAGE gel with apparent molecular mass of 30
kDa (supplemental Fig. 2A). Initial crystallization trials pro-
duced a P6 crystal form that diffracted to 1.60 Å. Attempts to
solve the SporoSAG structure using molecular replacement
with the individual core domains of SAG1 (25) and BSR4 (28,
46) as search models were unsuccessful. Additional rounds of
crystallization produced a cadmium-derivatized P21212 crystal
form from which we were able to generate high quality phases
using cadmium single-wavelength anomalous dispersion. It is
noteworthy that SporoSAG adopts a monomer in solution, as
shown by gel filtration chromatography, and crystallizes as a
monomer in both crystal forms (supplemental Fig. 2, B and C).
The absence of an observed dimer for SporoSAGcontrasts with
the structures of SAG1, which crystallized as a dimer (25), and
BSR4 that showed a clear dimer along the crystallographic
2-fold axis (28), suggesting that SporoSAGmay exist as a mon-
omer on the cell surface of the parasite. However, the physio-
logical GPI tether that is absent in our recombinant construct
may be required to promote dimerization of SporoSAG on the
parasite cell surface.
The overall structure of SporoSAG is comprised of tandem
-sandwich domains tethered by a short linker. Despite the
FIGURE3.Overall structureofSporoSAG.A, gene construct of T. gondiiType
II SporoSAG. The insect cell-produced construct extends from Pro-3 to Val-
237. The blue region denotes the signal sequence cleaved in the mature pro-
tein, and Ser238denotes the predictedGPI anchor site. B, secondary structure
representation of SporoSAG in the native P6 form (left panel) and the cad-
mium (orange spheres)-bound P21212 form (right panel). The SporoSAG
monomers are presentedwith the c-terminal end, which is modified by a GPI
anchor in the parasite, directed toward the cell surface membrane. C, cross-
eyed stereo view of a 2Fo Fc A-weighted electron density map of the D1
domain of SporoSAG contoured at 1.2 . All structure figures were prepared
with PyMOL (48).
FIGURE 4. Structural divergence in the SRS fold. A, top panel, secondary
structure depiction of native SporoSAG highlighting the strand structure
(blue) of the SRS -sandwich fold. Bottom panel, structural superposition of
the upper and lower -sheets of the -sandwich fold from SporoSAG (blue),
SAG1 (orange), and BSR4 (magenta). The upper -sheets of both the D1 and
the D2 domains of SporoSAG show significant structural divergence when
compared with SAG1 and BSR4, whereas the lower -sheets are largely con-
served. B, secondary structure view highlighting the unexpectedly structur-
ally equivalent disulfide bond in theD2domain of SporoSAG (blue) relative to
the D1 domain of SporoSAG, the D2 domain of SAG1 (orange) and the D2
domain of BSR4 (magenta), which show a spatially conserved disulfide bond.
The new disulfide-bonding pattern in SporoSAG is due to a sequence-shifted
cysteine (Cys-220) that appears to be selected for in members of the SAG2
subfamily. Secondary structure assignment is correlated to sequence in
supplemental Fig. 1.
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incorporation of two proline residues (Pro-131 and Pro-134),
the linker appears to be flexible as evidenced by its ability to
accommodate distinct relative orientations of the N-terminal
(D1) andC-terminal (D2) domains in the two crystal forms (Fig.
3B). In the P6 crystal form (Fig. 3B), the tandem domains are
organized in a head-to-tail fashion with the linker adopting a
bowed-out conformation, whereas in the P21212 form (Fig. 3B),
the linker adopts a more linear structure with the D2 domain
reoriented and positioned orthogonally to the long axis of the
D1 domain. Ultimately, the orientations of the SRS domains in
these two crystal forms reflect the potential for reorganization
on the parasite cell surface. Despite these spatial differences,
the overall structures of the individual domains are well
ordered, displaying clear electron density (Fig. 3C), and are
largely conserved with root mean square deviations between
the D1 domains and between the D2 domains for the two crys-
tal forms of 0.42 and 0.38 Å, respectively.
Structural Divergence in the SRS -Sandwich Fold—Our
bioinformatic analysis clearly shows that SporoSAG is a mem-
ber of the SAG2 subfamily. To determine how this sequence-
based classification translates to the structural level, we com-
pared the structure of SporoSAG with SAG1 (25) and BSR4
(28). A DALI search revealed that SporoSAG is the most struc-
turally divergent of the three. SporoSAG possesses z-scores of
12.3 and 10.3, respectively, when compared with the D1
domains of SAG1 andBSR4. TheD2
domains are slightly more divergent
with z-scores of 11.4 and 10.0 rela-
tive to SAG1andBSR4, respectively.
By contrast, the z-scores between
BSR4 and SAG1 are 20.5 and 17.8
for the D1 and D2 domains, respec-
tively. A detailed analysis reveals
that this structural divergence is
primarily localized to the upper
leaves of each SRS domain (Fig. 4A).
This observation is intriguing when
analyzed in the context of SAG1 and
BSR4 where the upper leaves of D1
form part of an extended groove
that participates in dimerization
and is predicted to coordinate host
cell ligands (25, 28).
Despite the structural bifurcation
of D1 and D2, the position of the
three key disulfide bonds that serve
as primary determinants for the SRS
fold are spatially conserved between
SporoSAG, SAG1, and BSR4. Two
pairs of disulfide bonds are respon-
sible for stitching the upper and
lower leaves of the -sandwich and
show less than 0.4 Å between the
three structures. Sequence align-
ment, however, predicted a reorga-
nization in the third disulfide bond
of the SporoSAG D2 domain as
Cys-220 was significantly shifted in
sequence relative to SAG1. Intriguingly, the repositioned cys-
teine aligns with one of the cysteines in SAG2A, consistent with
our bioinformatic assessment of SporoSAG as a member of the
SAG2 subfamily. However, it is also evident from the sequence
alignment that the third disulfide bond is not absolutely con-
served and is even predicted to be absent in the D2 domain of
some SAG2A family sequences, specifically SAG2C and
SAG2Y. A comparative structural analysis reveals that despite
the deviation in Cys-220 in the SporoSAG primary sequence,
the local structure is largely unperturbed relative to SAG1 (25)
and BSR4 (28). This is reflected in a pair of antiparallel strands
in SAG1 (Cys-182 3 Glu-192) and BSR4 (Cys-218 3 Thr-
230), which are connected by a short loop stabilized by a disul-
fide bond (SAG1, Cys-182 and Cys-190; BSR4, Cys-218 and
Cys-228) (Fig. 4B). Although the interstrand loop is conserved
in SporoSAG (Leu-174 3 Glu-182), the stabilizing disulfide
bond is reorganized such that Cys-179 bonds with Cys-218 on
16, thereby tethering the loop directly to the core -sandwich
(Fig. 4B). It appears then that at least in this region of Sporo-
SAG, that sequence, rather than structural divergence, may be
the essential feature.
Substituting the Basic Groove for an Acidic Cap—Unambig-
uous definition of the most biologically relevant orientation of
SporoSAG on the parasite cell surface is difficult and beyond
the scope of the structural studies presented here. Definitive
FIGURE 5. Implications for ligand binding. A, surface electrostatic calculations of native SporoSAG oriented
with the D2 domain proximal to the membrane and the D1 domain distal to the membrane as predicted for
SAG1 (25) and BSR4 (28). Note the acidic patch that caps the D1 domain of SporoSAG. Of the six acidic residues
in SporoSAG, none are conserved in SAG1, and only two are conserved in BSR4. B, top view of the SAG1 dimer
highlighting the basic groove and the same top view of the SporoSAG, SAG1, and BSR4 monomers along the
SAG1 dimer axis. None of the five basic residues in SAG1 are conserved in SporoSAG, and only two are con-
served inBSR4.Of particular interest is the spatial substitutionof the central Lys-33 in SAG1andLys-117 inBSR4
with Asp-81 in SporoSAG. C, ribbon diagram showing the total lack of polymorphism in SporoSAG among all
alleles PCR-amplified and DNA-sequenced for representative strains among the 11 haplogroups of T. gondii
strains when compared with SAG1 and BSR4 that display significant polymorphism (yellow spheres represent
polymorphic residues). Note that the polymorphisms do not align with the charged groove of BSR4.
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orientation is complicated by the absence of the GPI anchor in
the recombinant protein and the observed flexibility in the
interdomain linker. Combined, these features may promote
multiple orientations of SporoSAG on the cell surface with dis-
tinct potential for multimerization and ligand recognition.
However, to develop testable hypotheses designed to correlate
structure with function, we compared the native P6 crystal
formof SporoSAGwith the high resolution crystal structures of
SAG1 (25) and BSR4 (28). The P6 form was chosen because it
most closely approximates the domain orientation observed in
SAG1 (25) and BSR4 (28). For the sake of completeness, we
have also incorporated a discussion, albeit more limited, of the
P21212 SporoSAG crystal form.
An electrostatic surface representation of SporoSAG ori-
ented perpendicular to the membrane shows a predominantly
acidic surface at the membrane-distal region of D1 (Fig. 5A).
The cap of SporoSAGD1 is dominated by acidic residuesGlu-7,
Glu-9, Glu-33, Glu-34, Glu-72, and Asp-81, which are chemi-
cally distinct from the spatially analogous residues in SAG1 (25)
and BSR4 (28) (Fig. 5, A, left table, and B). One feature that is
particularly interesting is the substitution of Asp-81 in
SporoSAG for Lys-33 in SAG1 (Lys-117 in BSR4) that forms the
core of the basic groove predicted to play a role in coordinating
negatively charged sulfated proteoglycans such as heparin (25).
Intriguingly, Asp-81 is located on strand 7 that forms part of
the divergent upper sheet of the SporoSAG D1 domain (Fig.
4B). In contrast to Asp-81, the majority of acidic residues in
SporoSAG D1 tend to be more apically located than the
analogous residues in SAG1 and BSR4. This, along with the
observation the SporoSAG adopts a monomer in solution
(supplemental Fig. 2), may suggest a functional role that relies
onmolecular crowding to generate a broad acidic surface rather
than the dimerization observed in SAG1 and BSR4.We cannot,
however, discount the possibility that SporoSAG adopts a form
on the cell surface that more closely approximates the P21212
crystal. In this form, the acidic surface would be less likely to
project outwards. Instead, a more weakly charged surface
would be exposed that would likely require formation of a con-
torted multimer to form a contiguous electrostatic surface.
To assess the degree of polymorphism in the acidic cap of
SporoSAG D1, we analyzed the sequences of the 11 haplo-
groups of T. gondii strains that currently define the popula-
tion genetic structure. Intriguingly, no polymorphisms were
observed, indicating a biological pressure to maintain its pri-
mary sequence (Fig. 5C). This total lack of diversity is sharply
contrasted by the large number of alleles found amongT. gondii
strains for other SRS genes, including bsr4 and sag3. Only the
D1 domain of SAG1 has previously been shown to be devoid of
polymorphism among extant strains of T. gondii, further sug-
gesting that SporoSAG has an important role in the biology of
Toxoplasma infection, consistentwith the previously published
results indicating that SporoSAG possesses a demonstrated
role in host cell attachment and invasion (47). To date, how-
ever, no ligand has been identified for SporoSAG.The extensive
acidic surface combined with the lack of a defined basic surface
in either crystal form suggests that SporoSAGmay coordinate a
family of ligands distinct to the tachyzoite-expressed SRS pro-
teins SAG1 and SAG3 that are predicted to bind a negatively
charged sulfated proteoglycan (25).
Conclusions—In this study, we have undertaken a detailed
immunological, bioinformatic, and structural characterization
of SporoSAG from T. gondii. Despite abundant expression of
SporoSAG on the infectious sporozoite, sera from patients do
not possess antibodies against SporoSAG. This may be due to
the speed at which sporozoites convert to tachyzoites during
infection; hence, their limited persistence is insufficient to elicit
an immune response. Our bioinformatic analysis clearly shows
that SporoSAG is a member of the SAG2 subfamily, consistent
with our structural analysis demonstrating that SporoSAG is
significantly divergent from SAG1 (25) and BSR4 (28), the only
other structures of SRS proteins solved to date. A detailed com-
parison revealed that the SRS fold is structurally divergent in
the upper leaves of the D1 and D2 domains, whereas the lower
leaves are structurally conserved. This divergent feature is not
predicted at the level of primary sequence and provides intrigu-
ing insight to understanding the complexities of the SRS fold
that may be critical for ligand binding and multimerization.
Furthermore, our data show that the SporoSAG displays a neg-
atively charged surface at the tip of the D1 domain that con-
trasts with the positively charged surface of SAG1 and BSR4.
Whether the acidic surface of SporoSAG is functionally rele-
vant for ligand coordination remains to be determined. Finally,
a total lack of allelic polymorphism in SporoSAG among extant
Toxoplasma lineages provides a compelling new dimension for
this highly conserved, abundantly expressed protein that her-
alds a fresh newperspective in the evolution of functional diver-
sity within the SRS superfamily.
REFERENCES
1. Jackson, M. H., and Hutchison, W. M. (1989) Adv. Parasitol. 28, 55–105
2. McCabe, R. E., and Remington, J. S. (1983) Eur. J. Clin. Microbiol. 2,
95–104
3. Luft, B. J., Brooks, R. G., Conley, F. K., McCabe, R. E., and Remington, J. S.
(1984) JAMA 252, 913–917
4. Luft, B. J., and Remington, J. S. (1992) Clin. Infect. Dis. 15, 211–222
5. McDonald, J. C., Gyorkos, T. W., Alberton, B., MacLean, J. D., Richer, G.,
and Juranek, D. (1990) J. Infect. Dis. 161, 769–774
6. Nussenblatt, R. B., and Belfort, R., Jr. (1994) JAMA 271, 304–307
7. Silveira, C., Belfort, R., Jr., Burnier, M., Jr., and Nussenblatt, R. (1988)
Am. J. Ophthalmol. 106, 362–364
8. Grigg, M. E., Ganatra, J., Boothroyd, J. C., and Margolis, T. P. (2001) J. In-
fect. Dis. 184, 633–639
9. Tenter, A. M., Heckeroth, A. R., and Weiss, L. M. (2000) Int. J. Parasitol.
30, 1217–1258
10. Dubey, J. P., Saville, W. J., Stanek, J. F., and Reed, S. M. (2002) J. Parasitol.
88, 802–803
11. Dubey, J. P.,Weigel, R.M., Siegel, A.M., Thulliez, P., Kitron, U. D.,Mitch-
ell,M.A.,Mannelli, A.,Mateus-Pinilla, N. E., Shen, S. K., Kwok,O. C., et al.
(1995) J. Parasitol. 81, 723–729
12. Dubey, J. P., Zhu, X. Q., Sundar, N., Zhang, H., Kwok, O. C., and Su, C.
(2007) Vet. Parasitol. 145, 352–356
13. Sharif, M., Daryani, A., Nasrolahei, M., and Ziapour, S. P. (2009) Trop.
Anim. Health Prod. 41, 183–187
14. Smith, K. E., Zimmerman, J. J., Patton, S., Beran, G. W., and Hill, H. T.
(1992) Vet. Parasitol. 42, 199–211
15. Dubey, J. P. (2004) Vet. Parasitol. 126, 57–72
16. Bahia-Oliveira, L.M., Jones, J. L., Azevedo-Silva, J., Alves, C. C., Ore´fice, F.,
and Addiss, D. G. (2003) Emerg. Infect. Dis. 9, 55–62
17. Benenson,M.W., Takafuji, E. T., Lemon, S.M., Greenup, R. L., and Sulzer,
A. J. (1982) N. Engl. J. Med. 307, 666–669
Structural Characterization of SporoSAG
APRIL 16, 2010•VOLUME 285•NUMBER 16 JOURNAL OF BIOLOGICAL CHEMISTRY 12069
 at UQ Library on October 21, 2018
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
18. Bowie, W. R., King, A. S., Werker, D. H., Isaac-Renton, J. L., Bell, A., Eng,
S. B., and Marion, S. A. (1997) Lancet 350, 173–177
19. de Moura, L., Bahia-Oliveira, L. M., Wada, M. Y., Jones, J. L., Tuboi, S. H.,
Carmo, E. H., Ramalho, W. M., Camargo, N. J., Trevisan, R., Grac¸a, R. M.,
da Silva, A. J., Moura, I., Dubey, J. P., and Garrett, D. O. (2006) Emerg.
Infect. Dis. 12, 326–329
20. Dubey, J. P., Sharma, S. P., Juranek, D. D., Sulzer, A. J., and Teutsch, S. M.
(1981) Am. J. Vet. Res. 42, 1007–1010
21. Teutsch, S. M., Juranek, D. D., Sulzer, A., Dubey, J. P., and Sikes, R. K.
(1979) N. Engl. J. Med. 300, 695–699
22. Carruthers, V., and Boothroyd, J. C. (2007) Curr. Opin. Microbiol. 10,
83–89
23. Dzierszinski, F., Mortuaire, M., Cesbron-Delauw, M. F., and Tomavo, S.
(2000)Mol. Microbiol. 37, 574–582
24. Grimwood, J., and Smith, J. E. (1996) Int. J. Parasitol. 26, 169–173
25. He, X. L., Grigg, M. E., Boothroyd, J. C., and Garcia, K. C. (2002) Nat.
Struct. Biol. 9, 606–611
26. Mineo, J. R., and Kasper, L. H. (1994) Exp. Parasitol. 79, 11–20
27. Jung, C., Lee, C. Y., and Grigg, M. E. (2004) Int. J. Parasitol. 34, 285–296
28. Crawford, J., Grujic, O., Bruic, E., Czjzek, M., Grigg, M. E., and Boulanger,
M. J. (2009) J. Biol. Chem. 284, 9192–9198
29. Pei, J., Kim, B. H., and Grishin, N. V. (2008) Nucleic Acids Res. 36,
2295–2300
30. Drummond, A. J., Kearse, M., Heled, J., Moir, R., Thierer, T., Ashton, B.,
Wilson, A., and Stones-Havas, S. (2006)Geneious, version 2.5, Biomatters
Ltd., Auckland, New Zealand
31. Felsenstein, J. (1989) Cladistics 5, 164–166
32. Kong, J. T., Grigg, M. E., Uyetake, L., Parmley, S., and Boothroyd, J. C.
(2003) J. Infect. Dis. 187, 1484–1495
33. Pflugrath, J. W. (1999) Acta Crystallogr. D Biol. Crystallogr. 55,
1718–1725
34. Vonrhein, C., Blanc, E., Roversi, P., and Bricogne, G. (2007)Methods Mol.
Biol. 364, 215–230
35. Perrakis, A., Morris, R., and Lamzin, V. S. (1999) Nat. Struct. Biol. 6,
458–463
36. Vagin, A., and Teplyakov, A. (1997) J. Appl. Crystallogr. 30, 1022–1025
37. Emsley, P., and Cowtan, K. (2004)Acta Crystallogr. D Biol. Crystallogr. 60,
2126–2132
38. Murshudov, G. N., Vagin, A. A., and Dodson, E. J. (1997)Acta Crystallogr.
D Biol. Crystallogr. 53, 240–255
39. (1994) Acta Crystallogr. D Biol. Crystallogr. 50, 760–763
40. Bessie`res, M. H., Le Breton, S., and Se´gue´la, J. P. (1992) Parasitol. Res. 78,
222–228
41. Khan, I. A., Eckel,M. E., Pfefferkorn, E. R., andKasper, L.H. (1988) J. Infect.
Dis. 157, 979–984
42. Lau, Y. L., and Fong, M. Y. (2008) Exp. Parasitol. 119, 373–378
43. Partanen, P., Turunen, H. J., Paasivuo, R. T., and Leinikki, P. O. (1984)
J. Clin. Microbiol. 20, 133–135
44. Prigione, I., Facchetti, P., Lecordier, L., Desle´e, D., Chiesa, S., Cesbron-
Delauw, M. F., and Pistoia, V. (2000) J. Immunol. 164, 3741–3748
45. Jones, J. L., Kruszon-Moran, D., andWilson, M. (2003) Emerg. Infect. Dis.
9, 1371–1374
46. Grujic, O., Grigg, M. E., and Boulanger, M. J. (2008) Acta Crystallogr Sect.
F Struct. Biol. Cryst. Commun. 64, 425–427
47. Radke, J. R., Gubbels, M. J., Jerome, M. E., Radke, J. B., Striepen, B., and
White, M. W. (2004)Mol. Microbiol. 52, 93–105
48. DeLano, W. L. (2002) The PyMOL Molecular Graphics System, DeLano
Scientific LLC, San Carlos, CA
Structural Characterization of SporoSAG
12070 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 285•NUMBER 16•APRIL 16, 2010
 at UQ Library on October 21, 2018
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
Martin J. Boulanger
Joanna Crawford, Erika Lamb, James Wasmuth, Ognjen Grujic, Michael E. Grigg and
SURFACE ANTIGEN FROM TOXOPLASMA GONDII
Structural and Functional Characterization of SporoSAG: A SAG2-RELATED
doi: 10.1074/jbc.M109.054866 originally published online February 17, 2010
2010, 285:12063-12070.J. Biol. Chem. 
  
 10.1074/jbc.M109.054866Access the most updated version of this article at doi: 
 Alerts: 
  
 When a correction for this article is posted•  
 When this article is cited•  
 to choose from all of JBC's e-mail alertsClick here
Supplemental material:
  
 http://www.jbc.org/content/suppl/2010/02/17/M109.054866.DC1
  
 http://www.jbc.org/content/285/16/12063.full.html#ref-list-1
This article cites 46 references, 3 of which can be accessed free at
 at UQ Library on October 21, 2018
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
